On March 17, 2026, Picard Medical, Inc. announced that a 29-year-old patient was supported by the SynCardia Total Artificial Heart for over 1,600 days before receiving a heart transplant on February 24, 2026. This filing highlights the life-saving impact of their technology in critical cases.